-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Novel Monoclonal Antibodies in Acute Lymphocytic Leukemia

Program: Education Program
Session: Novel Approaches to Acute Lymphoblastic Leukemia
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Tangerine 3 (WF3-4), Level 2 (Orange County Convention Center)
Saturday, December 5, 2015, 4:00 PM-5:30 PM
Tangerine 2 (WF2), Level 2 (Orange County Convention Center)

Daniel J. DeAngelo, MD, PhD

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

tbd

Disclosures: DeAngelo: Bristol Myers Squibb: Consultancy ; Incyte: Consultancy ; Amgen: Consultancy ; Ariad: Consultancy ; Novartis: Consultancy ; Pfizer: Consultancy ; Agios: Consultancy ; Celgene: Consultancy .

See more of: Novel Approaches to Acute Lymphoblastic Leukemia
See more of: Education Program
Previous Presentation | Next Presentation >>